The Reciprocity between Radiotherapy and Cancer Immunotherapy

The clinical success of immune checkpoint inhibitors in treating metastatic and refractory cancers has generated significant interest in investigating their role in treating locally advanced diseases, thus requiring them to be combined with standard treatments in the hope of producing synergistic an...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cancer research 2019-03, Vol.25 (6), p.1709-1717
Hauptverfasser:	Wang, Yifan, Liu, Zhi-Gang, Yuan, Hengfeng, Deng, Weiye, Li, Jing, Huang, Yuhui, Kim, Betty Y S, Story, Michael D, Jiang, Wen
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic Agents, Immunological - pharmacology Antineoplastic Agents, Immunological - therapeutic use Cell Line, Tumor Clinical Trials as Topic Combined Modality Therapy - methods Costimulatory and Inhibitory T-Cell Receptors - antagonists & inhibitors Costimulatory and Inhibitory T-Cell Receptors - immunology Disease Models, Animal Humans Immunotherapy - methods Neoplasms - immunology Neoplasms - therapy Radiation Tolerance - drug effects Radiation Tolerance - immunology Radiotherapy - methods Research Design T-Lymphocytes - drug effects T-Lymphocytes - immunology T-Lymphocytes - radiation effects Tumor Escape - radiation effects Tumor Microenvironment - immunology Tumor Microenvironment - radiation effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!